Publications – Frailty Prevention (Peer Reviewed)

  1. Adachi JD, Cranney A, Goldsmith CH, Bensen WG, Bianchi F, Cividino A, Craig GL, Kaminska E, Sebaldt RJ, Papaioannou A, Boratto M, Gordon M, Steele M.  Intermittent cyclic therapy with etidronate in the prevention of corticosteroid induced bone loss.  J Rheumatol. 1994  Oct;21(10):1922-6.
     
  2. Papaioannou A, Adachi JD, Gagnon M, Turpie I, Cividino A, Beckingham A, Butson T. A model for osteoporosis education of students and health professionals. Drug Information Journal 1997;31:287-91.
     
  3. Parkinson W, Casperson E, Kumbare D, Dunlop B, Allega R, Adachi JD, Papaioannou A, Cott A.  Incidence of treatable phychosocial problems in back pain disability.  Pain Res Manage. 1997;2:62.
     
  4. Papaioannou A, Parkinson W, Adachi J, O’Connor A, Jolly EE, Tugwell P, Bedard M. Women’s decisions about hormone replacement after education and bone densitometry. Can Med Assoc J. 1998;159(10):1253-1257.
     
  5. Hansen S, Freitag AP, Hennessey R, Papaioannou A, Ioannidis G, Pickard L, Webber CE, Adachi JD.  The prevalence and risk factors of osteoporosis in a Canadian adult cystic fibrosis center population.  Pediatric Pulmonology 1999;suppl 19 pg 298.
     
  6. Papaioannou A, Clarke, JA, Heckman G.  Appropriate prescribing for cardiac disease in the elderly.  Journal of Clinical Outcomes Management 2000;7(4):47-54.
     
  7. Brenckman C, Papaioannou A, Haworth C, Aris R, Adachi JD. Bisphosphonates for bone disease in people with cystic fibrosis. Cochrane Database of Syst Rev. 2000;(2): Review.
     
  8. Papaioannou A, Wiktorowicz M, Adachi JD, Goeree R, Papadimitropoulos E, Bédard M, Brazil K, Parkinson W, Weaver B. Mortality, independence in living, and re-fracture, one year following hip fracture in Canadians.  J Soc Obstet Gynaecol Can. 2000;22(8):591-597.
     
  9. Papaioannou A, Clarke JA, Ioannidis G, Adachi J.  Achieving adherence with osteoporosis therapies.  Osteoporosis Management Today 2000;2(2):3-7.
     
  10. Papaioannou A, Clarke JA, Campbell G, Bedard M.  Assessment of adherence to renal dosing guidelines in long-term care facilities.  J Am Geriatr Soc. 2000 Nov;48(11):1470-3.
     
  11. Tenenhouse A, Joseph L, Kreiger N, Poliquin S, Murray TM, Blondeau L, Berger C, Hanely DA, Prior JC, and the CaMos Research Group.  Estimation of the prevalence of low bone density in Canadian women and men using a population-specific DXA reference standard: the Canadian Multicentre Osteoporosis Study (CaMos).  Osteoporosis Int. 2000;10:897-904.
     
  12. Hopman W, Towheed T, Anastassiades T, Tenenhouse A, Poliquin S, Berger C, Joseph L, Brown J, Murray T, Adachi JD, Hanley D, Papadimitropoulos M, and the CaMos Research Group.  Canadian normative data for the SF-36 Health Survey. CMAJ. 2000;163(3):265-271.
     
  13. Heckman GA, Papaioannou A, Parkinson W, Patterson CA.  Beta-blockers as first-line therapy for hypertension.  CMAJ. 2000 Nov 28;163(11):1424-5.
     
  14. Brenckmann C, Papaioannou A.  Bisphosphonates for bone disease in people with cystic fibrosis. Cochrane Database Syst Rev. 2001;(4):CD002010.
     
  15. Darzins P, Papaioannou A, Fleet N, Bédard M, Brown L, Millar P, Campbell G. A program to reduce the use of “high-risk” medications associated with falls in a long-term care facility. Annals RCPSC. 2001;34(1):6-10.
     
  16. Papaioannou A, Parkinson W, Adachi JD, Clarke JA.  Feasibility of day-hospital rehabilitation program early post-discharge after hip fractures.  Annals RCPSC. 2001;34(2):84-88.
     
  17. Papaioannou A, Adachi JD, Patterson C.  Osteoporosis and the Older Adult.  Compendium of Pharmaceuticals and Specialties (CPS).  2001, L24-L25.
     
  18. Papaioannou A, Ferko NC, Adachi JD.  All patients with inflammatory bowel disease should have bone density assessment.  Inflamm Bowel Dis. 2001 May;7(2):158-62; discussion 168-9.
     
  19. Wiktorowicz M, Goeree R, Papaioannou A, Adachi JD, Papadimitropoulos E.  Economic implications of hip fracture: health service use, institutional care and cost in Canada.  Osteoporos Int. 2001;12(4):271-8.
     
  20. Adachi JD, Papaioannou A.  Corticosteroid-induced osteoporosis: detection and management.  Drug Saf. 2001;24(8):607-24.
     
  21. Loeb M, Brazil K, Durand P, Gordon M, Krueger P, Lewis D, Lohfeld L, McGeer A, Nicolle L, Papaioannou A, Simor A.  Identifying research priorities on infections in older adults: proceedings of an interdisciplinary workshop.  BMC Geriatr. 2001;1:1.
     
  22. Papaioannou A, Adachi JD, Parkinson W, Stephenson G, Bedard M.  Lengthy hospitalization associated with vertebral fractures despite control for comorbid conditions. Osteoporos Int. 2001;12(10):870-4.
     
  23. Papaioannou A, Ray JG, Clarke JA, Campbell G, Adachi JD, Ferko NC.  Estimation of creatinine clearance in elderly persons in long term care facilities. Am J Med. 2001 Nov;111(7):569-73.
     
  24. Adachi JD, Ioannidis G, Berger C, Joseph L, Papaioannou A, Pickard L, Papadimitropoulos EA, Hopman W, Poliquin S, Prior JC, Hanley DA, Olszynski WP, Anastassiades T, Brown JP, Murray T, Tenenhouse A, the CaMos Research Group.  The influence of osteoporotic fractures on health related quality of life in community dwelling men and women across Canada.  Osteoporos Int. 2001;12(11):903-8.
     
  25. Adachi JD, Ioannidis G, Olszynski WP, Brown JP, Hanley DA, Sebaldt Rj, Petrie A, Tenenhouse A, Stephenson GF, Papaioannou A, Guyatt GH, Goldsmith CH.  The impact of incident vertebral and non-vertebral fractures on health related quality of life in postmenopausal women.  BMC Musculoskelet Disord 2002 Apr 23;3:11.
     
  26. Heckman GA, Papaioannou A, Sebaldt RJ, Ioannidis G, Petrie A, Goldsmith C, Adachi JD.  Effect of vitamin D on bone mineral density of elderly patients with osteoporosis responding poorly to bisphosphonates.  BMC Musculoskelet Disord. 2002;3:6.
     
  27. Ray JG, Papaioannou A, Ioannidis G, Adachi JD.  Anticonvulsant drug use and low bone mass in adults with neurodevelopmental disorders.  QJM. 2002 Apr;95(4):219-23.
     
  28. Ioannidis G, Papaioannou A, Adachi JD.  Quality of life impacts osteoporosis fracture outcomes.  Bio Mechanics. 2002;9(6):27-34.
     
  29. Cranney A, Tugwell, P, Adachi J, Weaver B, Zytaruk N, Papaioannou A, Robinson V, Shea B, Wells G, Guyatt G; Osteoporosis Methodology Group and The Osteoporosis Research Advisory Group.  Meta-analysis of therapies for postmenopausal osteoporosis. III. Meta-analysis of risedronate for the treatment of postmenopausal osteoporosis. Endocr Rev. 2002 Aug;23(4):517-23. Review.
     
  30. Papaioannou A, Watts NB, Kendler DL, Yuen CK, Adachi JD, Ferko N.  Diagnosis and management of vertebral fractures in elderly adults.  Am J Med. 2002 Aug 15;113(3):220-28.
     
  31. Olszynski WP, Ioannidis G, Sebaldt RJ, Hanley DA, Petrie A, Brown JP, Josse RG, Murray TM, Goldsmith CH, Stephenson GF, Papaioannou A, Adachi JD.  The association between iliocostal distance and the number of vertebral and non-vertebral fractures in women and men registered in the Canadian Database for Osteoporosis and Osteopenia (CANDOO).  BMC Musculoskelet Disord. 2002 Oct 3;3:22. 
     
  32. Kherani RB, Papaioannou A, Adachi JD.  Long-term tolerability of the bisphosphonates in postmenopausal osteoporosis: a comparative review.  Drug Saf. 2002; 25(11):781-90.
     
  33. Papaioannou A, Bedard M, Campbell G, Dubois S, Ferko N, Heckman G, Flett N.  Development and use of a computer program to detect potentially inappropriate prescribing in older adults residing in Canadian long-term care facilities.  BMC Geriatr. 2002 Oct 14;2:5.
     
  34. Body JJ, Gaich GA, Scheele WH, Miller PD, Peretz A, Dore RK, Correa-Rotter R, Papaioannou A, Cumming DC, Hodsman AB.  A randomized double-blind trial to compare the efficacy of teriparatide [recombinant human parathyroid hormone (1-34)] with alendronate in postmenopausal women with osteoporosis.  J Clin Endocrinol Metab. 2002 Oct;87(10):4528-35.
     
  35. Hopman WM, Berger C, Joseph L, Towhead T, Anastassiades T, Tenenhouse A, Poliquin S, Brown JP, Murray TM, Adachi JD, Hanley DA, Papadimitropoulos, and the CaMos Research Group.  Is there regional variation in the SF-36 scores of Canadian adults. Can J Public Health 2002;93:233-237.
     
  36. Papaioannou A, Ioannidis G, Adachi J, Sebaldt R, Ferko N, Puglia M, Brown J, Tenenhouse A, Olszynski P, Boulos P, Hanley DA, Josse R, Murray T, Petrie A, Goldsmith C.  Adherence to bisphosphonates and hormone replacement therapy in a tertiary care setting of patients in the CANDOO database.  Osteoporos Int. 2003 Oct;14(10):808-13.
     
  37. Papaioannou A, Parkinson W, Ferko N, Probyn L, Ioannidis G, Jurriaans E, Cox G, Cook RJ, Kumbhare D, Adachi JD.  Prevalence of vertebral fractures among patients with chronic obstructive pulmonary disease in Canada.  Osteoporos Int. 2003 Nov;14(11):913-17.
     
  38. Kolbe F, Sitar DS, Papaioannou A, Campbell G. An Amantadine Dosing Program Adjusted for Renal Function During an Influenza Outbreak in Elderly Institutionalized Patients. Can J Clin Pharmacol. 2003 Fall;10(3):119-22.
     
  39. Papaioannou A, Adachi JD, Winegard K, Ferko N, Parkinson W, Cook RJ, Webber C, McCartney N.  Efficacy of home-based exercise for improving quality of life among elderly women with symptomatic osteoporosis-related vertebral fractures.  Osteoporos Int. 2003 Aug;14(8):677-82.
     
  40. Brenckmann C, Papaioannou A, Freitag A, Hennessey R, Hansen S, Ioannidis G, Webber C, Adachi JD.  Osteoporosis in Canadian adult cystic fibrosis patients.  BMC Musculoskelet Disord. 2003 Jun 24;4:13.
     
  41. Webber CE, Papaioannou A, Winegard KJ, Adachi JD, Parkinson W, Ferko N, Cook RJ, McCartney.  A six month home-based exercise program may slow vertebral height loss.  J Clin Densitom. 2003;6(4)391-400. 
     
  42. Adachi JD, Ioannidis G, Pickard L, Berger C, Prior JC, Joseph L, Hanley DA, Olszynski WP, Murray TM, Anastassiades T, Hopman W, Brown JP, Kirkland S, Joyce C, Papaioannou A, Poliquin S, Tenenhouse A, Papadimitropoulos EA.  The association between osteoporotic fractures and health related quality of life as measured by the Health Utilities Index in the Canadian Multicentre Osteoporosis Study (CaMos).  Osteoporos Int. 2003 Nov;14(11):894-904.
     
  43.  Boulos P, Papaioannou A, Adachi JD.  Prevention and treatment of corticosteroid-induced osteoporosis in ­the elderly.  Annals of Long-Term Care: Clinical Care and Aging 2003;Vol 11(1):42-48.
     
  44. Beattie K, Papaioannou A, Boulos P, Adachi R.  Kyphoplasty and vertebroplasty for the treatment of osteoporotic vertebral compression fractures.  Geriatrics and Aging 2003;Vol 6(2):47-52.
     
  45. Kherani RB, Papaioannou A, Adachi JD.  Bisphosphonates in postmenopausal osteoporosis: a comparative review of long-term safety issues.  New Ethicals Journal 2003;45-52.
     
  46. Hanley DA, Brown J, Tenenhouse A, Olszynski WP, Ioannidis G, Berger C, Prior JC, Pickard L, Murray TM, Anastassiades T, Kirkland S, Joyce C, Joseph L, Papaioannou A, Jackson SA, Poliquin S, Adachi JD; Canadian Multicentre Osteoporosis Study Research Group.  Associations among disease conditions, bone mineral density and prevalent vertebral deformities in men and women 50 years of age and older: cross-sectional results from the Canadian Multicentre Osteoporosis Study.  J Bone Miner Res.  2003 Apr;18(4):784-90.
     
  47. Bedard M, Klein R, Papaioannou A, Motyka S, Hutchinson L.  Renal impairment and medication use among psychogeriatric inpatients.  Can J Clin Pharmacol. 2003 Summer;10(2):78-82.
     
  48. Cranney A, Waldegger L, Zytaruk N, Shea B, Weaver B, Papaioannou A, Robinson V, Wells G, Tugwell P, Adachi JD, Guyatt G. Risedronate for the prevention and treatment of postmenopausal osteoporosis. Cochrane Database Syst Rev. 2003;(4)CD004523. Update in: Cochrane Database Syst Rev. 2006;(1):CD004523.
     
  49. Sawka AM, Adachi JD, Ioannidis G, Olszynski WP, Brown JP, Hanley DA, Murray T, Josse R, Sebaldt RJ, Petrie A, Tenenhouse A, Papaioannou A, Goldsmith CH. What predicts early fracture or bone loss on bisphosphonate therapy? J Clin Densitom. 2003 Winter;6(4):315-22.
     
  50. Webber CE, Papaioannou A, Winegard KJ, Adachi JD, Parkinson W, Ferko NC, Cook RJ, McCartney N. Six month home-based exercise program may slow vertebral height loss. J Clin Densitom. 2003 Winter;6;391-400.
     
  51. VanDenKerhkof EG, Hopman WM, Towheed TE, Anastassiades TP, Goldstein DH and the CaMos Research Group.  The impact of sampling and measurement on the prevalence of self-reported pain in Canada. Pain Res Manage. 2003;8(3):157-163.
     
  52. Vidal-Alaball J, Butler CC, Hood K, Cannings R, McCaddon A, Papaioannou A. Oral vitamin B12 versus parenteral vitamin B12 for vitamin B12 deficiency (Protocol for Cochrane Review). In: The Cochrane Library, Issue 1, 2004.
     
  53. Papaioannou A, Parkinson W, Cook R, Ferko N, Coker E, Adachi J.D.  Prediction of falls using a risk assessment tool in the acute care setting.  BMC Med. 2004 Jan;2:1.
     
  54. Papaioannou A, Giangregorio LM. Kvern B, Boulos P, Ioannidis G, Adachi J.D.  The osteoporosis care gap in Canada.  BMC Musculoskelet Disord. 2004 Apr 6;5:11. Review.
     
  55. Papaioannou A, Ferko N.  Cystic fibrosis and osteoporosis.  SVB ACFCQ 28th Edition 2004;15-19.
     
  56. Garg A.X., Papaioannou A, Ferko N, Campbell G, Clarke J, Ray J.   Estimating the prevalence of renal insufficiency in seniors requiring long-term care.  Kidney Int. 2004 Feb;65(2):649-53.
     
  57. Mathoo JM, Cranney A, Papaioannou A, Adachi JD.  Rational use of oral bisphosphonates for the treatment of osteoporosis.  Curr Osteoporos Rep. 2004 Mar;2(1):17-23. Review.
     
  58. Papaioannou A, Ferko NC, Adachi JD, Watts N.  Screening for osteoporosis.  Physician’s Information and Education Resource (PIER). American College of Internal Medicine – Electronic Web-based Decision Support Tool. May 2004 http://pier.acponline.org/index.html
     
  59. Papaioannou A.  Estrogen plus progestin reduced risk for fracture in postmenopausal women.  ACP J Club. 2004 May-Jun;140(3):61.
     
  60. Sawka A, Adachi JD, Papaioannou A, Thabane L, Ioannidis G, Davison S, Olszynski WP, Brown JP, Hanley DA, Murray T, Josse R, Sebaldt R, Petrie A, Tenenhouse A, Goldsmith C.  Are there differences between men and women prescribed bisphosphonate therapy in Canadian subspecialty osteoporosis practices?  J Rheumatol. 2004 Oct;31(10):1993-5.
     
  61. Sawka AM, Huh A, Adachi JD, Papaioannou A, Dolovich L, Eva K, Thabane L, Gafni A, Cullimore A, MacDougall M, Steiner M.  Attitudes of women who are currently using or recently stopped estrogen replacement therapy with or without progestins: results of the AWARE Survey.  J. Obstet Gynaecol Can. 2004 Nov;26(11):967-73.
     
  62. Hopman WM, Berger C, Joseph L, Towheed T, VandenKerkhof E, Anastassiades T, Cranney A, Adachi JD, Ioannidis G, Poliquin S, Brown JP, Murray TM, Hanley DA, Papadimitropoulos EA, Tenenhouse A, and the CaMos Research Group.  Stability of normative data for the SF-36: results of a three-year prospective study in middle-aged Canadians. CJPH. 2004;95(5):387-391.
     
  63. Sawka A, Thabane L, Papaioannou A, Gafni A, Hanley DA, Adachi JD.  A Systematic Review of the Effect of Alendronate on Bone Mineral Density in Men.  J Clin Densitom. 2005 Spring;8(1):7-13. Review.
     
  64. Papaioannou A, Joseph L, Ioannidis G, Berger C, Anastassiades T, Brown JP, Hanley DA, Hopman W, Josse RG, Kirkland S, Murray TM, Olszynski WP, Pickard L, Prior JC, Siminoski K, Adachi JD.  Risk factors associated with incident clinical vertebral and nonvertebral fractures in postmenopausal women: the Canadian Multicentre Osteoporosis Study (CaMos). Osteoporos Int. 2005 May;16(5):568-78.
     
  65. Sawka A, Boulos P, Beattie K, Thabane L, Papaioannou A, Gafni A, Cranney A, Zytaruk N, Hanley DA, Adachi JD.  Do hip protectors decrease the risk of hip fracture in institutional and community dwelling elderly?  A Systematic Review and Meta-analysis of Randomized Controlled Trials.  Osteoporos Int. 2005 Dec;16(12):1461-74.
     
  66. Kumbhare DA, Balsor B, Parkinson WL, Bsckin P, Bedard M, Papaioannou A, Adachi JD.  Measurement of cervical flexor endurance following whiplash.  Disabil Rehabil. 2005 Jul 22;27(14):801-7.
     
  67. Vidal-Alaball J, Butler CC, Cannings-John R, Goringe A, Hood K, McCaddon A, Papaioannou A.  Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency. Cochrane Database of Syst Rev. 2005 Jul 20;(3):CD004655. Review
     
  68. Giangregorio LM, Papaioannou A, Adachi JD.  Osteoporosis:  Preventing the deterioration of bone.  Geriatrics & Aging 2005;8(7):60-66.
     
  69. Bensen R, Adachi JD, Papaioannou A, Ioannidis G, Olszynski W.J., Sebaldt R, Murray T, Josse R, Brown J, Hanley DA, Petrie A, Puglia M, Goldsmith C, Bensen W.  Evaluation of easily measured risk factors in the prediction of osteoporotic fractures. BMC Musculoskelet Disord. 2005 Sep 5;6:47.
     
  70. Brunton S, Carmichael B, Gold D, Hull B, Kauffman T, Papaioannou A, Rasch R, Stracke H, Truumees E.  Vertebral compression fractures in primary care.  J Fam Pract. 2005 Sep;54(9)781-8.
     
  71. Sawka A, Ioannidis G, Papaioannou A, Thabane L, Olszynski W , Brown J, Hanley DA, Murray T, Josse R, Sebaldt R, Petrie A. Tenenhouse A, Goldsmith CH, Boulos P, Kouroukis T, Adachi JD.  Are oral bisphosphonates effective in improving lumbar bone mineral density in breast cancer survivors with osteopenia or osteoporosis?  J Obstet Gynaecol Can. 2005 Aug;27(8):759-64.
     
  72. Sawka A, Papaioannou A, Adachi JD, Gafni A, Hanley DA, Thabane L.  Does alendronate reduce the risk of fracture in men?  A meta-analysis incorporating prior knowledge of anti-fracture efficacy in women.  BMC Musculoskelet Disord. 2005 Jul 11;6:39. Review.
     
  73. Sawka AM, Thabane L, Papaioannou A, Gafni A, Ioannidis G, Papadimitropoulos EA, Hopman WM, Cranney A, Hanley DA, Pickard L, Adachi JD; CaMos Investigators. Health-related quality of life measurements in elderly Canadians with osteoporosis compared to other chronic medical conditions: a population-based study from the Canadian Multicentre Osteoporosis Study (CaMos).  Osteoporos Int. 2005 Dec;16(12):1836-40.
     
  74. Strevel EL, Papaioannou A, Adachi JD, McNamara M.  Case report: osteogenesis imperfecta elusive cause of fractures.  Can Fam Physician. 2005 Dec;51:1655-7.
     
  75. Manlucu J, Tonelli M, Ray JG, Papaioannou A, Youssef G, Thiessen HR, Holbrook A, Garg AX.  Dose reducing H2 receptor antagonists in the presence of low glomerular filtration rate:  A systematic review of the evidence.  Nephrol Dial Transplant. 2005;20:2376-2384.
     
  76. Adachi JD, Papaioannou A.  In whom and how to prevent glucocorticoid-induced osteoporosis.  Best Pract Res Clin Rheumatol. 2005 Dec;19:1039-64.
     
  77. Sawka AM, Huh A, Dolovich L, Papaioannou A, Eva K, Thabane L, Gafni A, Cullimore A, Macdougall M, Steiner M, Adachi JD.  HRT use among women tested for breast mutations following publication of the women’s health initiative study results. J Obstet Gynecol Can. 2005;27:349-350.
     
  78. Cranney A, Waldegger L, Zytaruk N, Shea B, Weaver B, Papaioannou A, Robinson V, Wells G, Tugwell P, Adachi JD, Guyatt G. Risedronate for the prevention and treatment of postmenopausal osteoporosis. Cochrane Database Syst Rev. Update in: Cochrane Database Syst Rev. 2006;(1):CD004523.
     
  79.  Mathoo J, Cranney A, Papaioannou A, Adachi JD.  Rational use of oral bisphosphonates for the treatment of osteoporosis.  Curr Osteoporos Rep. 2005;2:17-23.
     
  80. Olszynski W.P., Ioannidis G, Davison S, Brown JP, Hanley DA, Josse, Murray TM, Papaioannou A, Sebaldt RJ, Tenenhouse A, Petrie A, Goldsmith C, Adachi JD.  Effectiveness of alendronate and etidronate in the treatment of osteoporosis in men: a prospective observational study.  Osteoporos Int. 2006 Feb;17(2):217-24.
     
  81. Kennedy CC, Papaioannou A, Adachi JD.  Glucocorticoid-induced osteoporosis.  Womens Health (London Engl). 2006 Jan;2(1):65-74.
     
  82. Brown JP, Fortier M, Frame H, Papaioannou A, Senikas V, Yuen CK; Osteoporosis Guidelines Committee.  Canadian Consensus Conference on osteoporosis.  J Obstet Gynaecol Can. 2006 Feb;28(2 Suppl 1):S95-112.
     
  83. Butler CC, Vidal-Alaball J, Cannings-John R, McCaddon A, Hood K, Papaioannou A, McDowell I, Goringe A.  Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency: a systematic review of randomized controlled trials.  Fam Pract. 2006 Jun;23(3):279-85.
     
  84. Papaioannou A, Kennedy CC, Ioannidis G, Brown JP, Pathak A, Hanley DA, Josse RJ, Sebaldt R, Olszynski WP, Tenenhouse A, Murray TM, Petrie A, Goldsmith CH, Adachi JD.  Determinants of health-related quality of life in women with vertebral fractures.  Osteoporos Int. 2006;17(3):355-63.
     
  85. Giangregorio LM, Papaioannou A, Cranney A, Zytaruk N, Adachi JD.  Fragility fractures and the osteoporosis care gap: an international phenomenon.  Semin Arthritis Rheum. 2006 Apr;35(5):293-305.
     
  86. Cranney A, Papaioannou A, Zytaruk N, Hanley DA, Adachi J, Goltzman D, Murray T, Hodsman A.  Parathyroid hormone for the treatment of osteoporosis: a systematic review.  CMAJ. 2006 Jul 4;175(1):52-9.
     
  87. Davison KS, Siminoski K, Adachi JD, Hanley DA, Goltzman D, Hodsman A, Josse R, Kaiser S, Olszynski W, Papaioannou A, St-Marie L, Kendler D, Tenenhouse A, Brown J.   Bone strength: the whole is greater than the sum of its parts.  Semin Arthritis Rheum.  2006 Aug;36(1):22-31. Review.
     
  88. Kennedy CC, Papaioannou  A, Adachi JD. Treating osteoporosis: economic aspects of bisphosphonate therapy. Expert Opin Pharmacother. 2006 Aug;7(11):1457-67. Review.
     
  89. Sawka AM, Papaioannou A, Josse R, Murray T, Ioannidis G, Hanley DA, Prior J, Thabane L, Papadimitropoulos E, Gafni A, Pickard L, Anastassiades T, Kirkland S, Adachi JD, and the CaMos Research Group.  What is the number of older Canadians needed to be screened by measurement of bone density to detect an undiagnosed case of osteoporosis? a population-based study from CaMos.  J Clin Densitom. 2006 Oct-Dec; 9(4):413-8.
     
  90. Davison K, Siminoski K, Adachi JD, Hanley DA, Goltzman D, Hodsman AB, Josse R, Kaiser S, Olszynski WP, Papaioannou A, Ste-Marie LG, Kendler DL, Tenenhouse A, Brown JP.  The effects of antifracture therapies on the components of bone strength: assessment of fracture risk today and in the future. Semin Arthritis Rheum. 2006 Aug; 36(1):10-21. Review.
     
  91. Hodsman A; ScientificAdvisory Council of Osteoporosis Canada, Papaioannou A; Clinical Guidelines Committee, Cranney A; Writing Group on the Systematic Review of Parathyroid Hormone for the Treatment of Osteoporosis.  Clinical practice guidelines for the use of parathyroid hormone in the treatment of osteoporosis. CMAJ. 2006 Jul 4;175(1):48-51.
     
  92. Hopman WM, Berger C, Joseph L, Towheed T, VandenKerkhof E, Anastassiades T, Adachi JD, Ioannidis G, Brown JP, Hanley DA, Papadimitropoulos EA, the CaMos Research Group.  The natural progression of health related quality of life: results of a five-year prospective study of SF36 scores in a normative population. Qual Life Res.  2006;15:527-536.
     
  93. Khan A, Hodsman AB., Papaioannou A, Kendler D, Brown JP, Olszynski WP. Management of osteoporosis in men: an update and case example. CMAJ. 2007 Jan 30; 176(3):345-8.
     
  94. Richards JB, Papaioannou A, Adachi JD, Joseph L, Whitson H, Prior JC, Goltzman D. Effect of selective serotonin reuptake inhibitors on the risk of fracture. Arch Int Med. 2007 Jan 22;167(2):188-94.
     
  95. Giangregorio LM, Fisher P, Papaioannou A, Adachi JD.  Osteoporosis knowledge and information needs in health care professionals caring for patients with fragility fractures. Orthop Nurs. 2007 Jan-Feb;26(1):27-35.
     
  96. Sawka AM, Gafni A, Boulos P, Beattie K, Papaioannou A, Cranney A, Hanley DA, Adachi JD, Cheung A, Papadimitropoulos EA, Thabane L.  Could a policy of provision of hip protectors to elderly nursing home residents result in cost savings in acute hip fracture care?  The case of Ontario, Canada.  Osteoporos Int. 2007 Jun;18(6):819-27.
     
  97. Richards JB, Leslie WD, Joseph L, Siminoski K, Hanley DA, Adachi JD, Brown JP, Morin S, Papaioannou A, Josse RG, Prior JC, Davison S, Tenenhouse AT, Goltzman D for the CaMos Study Group.  Changes to osteoporosis prevalence according to method of risk assessment. J Bone Miner Res. 2007 Feb;22(2):228-34.
     
  98. Papaioannou A, Kennedy CC, Dolovich L, Lau E, Adachi JD.  Patient Adherence with   osteoporosis medications: problems, consequences and management strategies. Drugs Aging. 2007;24(1):37-55. Review.
     
  99. Sawka AM, Nixon M, Giangregorio LM, Thabane L, Adachi JD, Gafni A, Goeree R, Raina P, Ranford J, Papaioannou A. The use of hip protectors in long-term care facilities: a survey of nursing home staff.  J Am Med Dir Assoc. 2007 May;8(4):229-32.
     
  100. Sawka AM, Boulos P, Beattie K, Papaioannou A, Gafni A, Cranney A, Hanley DA, Adachi JD, Papadimitropoulos EA, Thabane L.  Hip protectors decrease hip fracture risk in elderly nursing home residents: a bayesian meta-analysis.  J Clin Epidemiol. 2007 Apr;60(4):336-44. Review.  Erratum in: J Clin Epidemiol. 2008 Aug;61(8):854.
     
  101. Cranney A, Adachi JD, Guyatt G, Papaioannou A, Robinson VA, Shea BJ, Tugwell P, Waldegger LM, Weaver B, Wells G, Zytaruk N.  WITHDRAWN: Risedronate for the prevention of postmenopausal osteoporosis.  Cochrane Database Syst Rev. 2007 Jul 18;(1):CD004523. Review. Update in Cochrane Database Syst Rev. 2008;(1):CD004523.
     
  102. Kaasalainen S, Coker E, Dolovich L, Papaioannou A, Hadjistavropoulos T, Emili A, Ploeg J.  Pain management decision-making among long-term care physicians and nurses.  West J Nurs Res. 2007 Aug;29(5):561-8;discussion 581-8.
     
  103. Sawka AM, Boulos P,  Talib AS, Gafni A, Thabane L, Papaioannou A, G. Booth G, Gerstein HC.  Low socioeconomic status and increased risk of severe hypoglycemia in type 1 diabetes:  A systematic literature review.  Cdn J Diabetes.  2007;31(3):233-241.
     
  104. Ioannidis G, Papaioannou A, Thabane L, Gafni A, Hodsman A, Kvern B, Johnstone D, Plumley N, Crowley C, Baldwin A, Doupe M, Katz A, Salach L, Adachi J.  Canadian Quality Circle pilot project in osteoporosis: rationale, methods, and feasibility.  Can Fam Physician.  2007 Oct;53(10):1694-700. Erratum in: Can Fam Physician. 2007 Dec;53(12):2105.
     
  105. Balion, CM, Benson, C, Raina, PS, Papaioannou, A, Patterson, C, Ismaila, AS.  Brain type carnosinase in dementia: a pilot study.  BMC Neurol. 2007 Nov 5;7:38.
     
  106. Hopman WM, Leroux C, Berger C, Joseph L, Barr SI, Prior JC, Harrison M, Poliquin S, Towheed T, Anastassiades T, Goltzman D, and the CaMos Research Group.  Changes in Body Mass Index in Canadians Over a Five-Year Period: Results of a prospective, population-based study.  BMC Public Health. 2007;7:150.
     
  107. Prior JC, Burdge DR, Maan E, Milner R, Hankins C, Klein M, Walmsley S, Canadian Women’s HIV Study Group, and the CaMos Research Group.  Fragility fractures and bone mineral density in HIV positive women: A case control population-based study. Osteoporos Int. 2007 Oct;1345(10):1345-1353.
     
  108. Lau E, Papaioannou A, Dolovich L, Adachi J, Sawka AM, Burns S, Nair K, Pathak A. Patients’ adherence to osteoporosis therapy: exploring the perceptions of postmenopausal women. Can Fam Physician. 2008 Mar;54(3):394-402.
     
  109. Giangregorio L, Papaiaonnou A, Thabane L, DeBeer J, Cranney A, Dolovich L, Adili A, Adachi JD.  Do patients perceive a link between a fragility fracture and osteoporosis?  BMC Musculoskelet Disord. 2008 Mar 21;9:38.
     
  110. Coker E, Papaioannou A, Turpie I, Dolovich L, Taniguchi A, Kaasalainen S, Burns S.  Pain management practices with older adults on acute medical units. Perspectives. 2008 Spring;32(1):5-12.
     
  111. Grima DT, Papaioannou A, Thompson MF, Pasquale MK, Adachi JD.  Greater first year effectiveness drives favorable cost-effectiveness of brand risedronate versus generic or brand alendronate: modeled Canadian analysis. Osteoporos Int. 2008 May;19(5);687-97.
     
  112.  Verhovsek M, Motlagh B, Crowther MA, Kennedy C, Dolovich L, Campbell G, Wang L, Papaioannou A.  Quality of anticoagulation and use of warfarin-interacting medications in long-term care: a chart review.  BMC Geriatr. 2008 Jul 3;8:13.
     
  113. Beattie K, Bobba R, Bayoumi I, Chan D, Schabort I, Boulos P, Kean W, Obeid J, McCallum R, Ioannidis G, Papaioannou A, Cividino A.  Validation of the GALS musculoskeletal screening exam for use in primary care: a pilot study.  BMC Musculoskelet Disord.  2008 Aug 27;9:115.
     
  114. Papaioannou A, Kennedy C, Freitag A, Ioannidis G, O’Neill J, Webber C, Pui M, Berthiaume Y, Rabin HR, Paterson N, Jeanneret A, Matouk E, Villeneuve J, Nixon M, Adachi JD.  Alendronate once weekly for the prevention and treatment of osteoporosis in Canadian adult cystic fibrosis patients (CFOS trial). Chest. 2008 Oct;134(4):794-800.
     
  115. Howard M, Goertzen J, Kaczorowski J, Hutchison B, Morris K, Thabane L, Levine M, Papaioannou A.  Emergency department and walk-in clinic use in models of primary care practice with different after-hours accessibility in Ontario.  Healthc Policy. 2008 Aug;4(1):73-88.
     
  116. Papaioannou A, Kennedy C, Freitag A, O’Neill J, Pui M, Ioannidis G, Webber C, Pathak A, Hansen S, Hennessey R, Adachi JD.  Longitudinal analysis of vertebral fracture and BMD in a Canadian cohort of adult cystic fibrosis patients.  BMC Musculoskelet Disord. 2008 Sep 19;9:125.
     
  117. Ioannidis G, Thabane L, Gafni A, Hodsman A, Kvern B, Johnstone D, Plumley N, Salach L, Jiwa F, Adachi JD, Papaioannou A.  Optimizing care in osteoporosis: the Canadian quality circle project.  BMC Musculoskelet Disord. 2008 Oct 1;9:130.
     
  118. Labuda, A, Papaioannou A., Pritchard J, Kennedy C, DeBeer J, Adachi JD.  Prevalence of osteoporosis in osteoarthritic patients undergoing total hip or total knee arthroplasty.  Arch Phys Med Rehabil. 2008 Dec;89(12):2373-4.
     
  119. Oliver D, Papaioannou A, Giangregorio L, Thabane L, Reizgys K, Foster G.  A systematic review and meta-analysis of studies using the STRATIFY tool for prediction of falls in hospital patients: how well does it work? Age and Ageing. 2008 Nov;37(6):621-7.
     
  120. Lau AN, Ali SH, Sawka AM, Thabane L, Papaioannou A, Gafni A, Adachi JD.  Improvement in health-related quality of life in osteoporosis patients treated with teriparatide.  BMC Musculoskelet Disord. 2008 Nov 7;9:151.
     
  121. Berger C, Langsetmo L, Joseph L, Hanley DA, Davison KS, Josse R, Kreiger N, Tenenhouse A, Goltzman D, and the CaMos Research Group.  Changes in bone mineral density as a function of age in women and men and association with the use of antiresorptive agents. CMAJ. 2008;178:1660-1668.
     
  122. Papaioannou A, Kennedy CC, Ioannidis G, Gao Y, Sawka AM, Goltzman D, Tenenhouse A, Pickard L, Olszynski WP, Davison KS, Kaiser S, Josse RG, Kreiger N, Hanley DA, Prior JC, Brown JP, Anastassiades T, Adachi JD, and the CaMos Research Group.  The osteoporosis care gap in men with fragility fractures: The Canadian Multicentre Osteoporosis Study.  Osteoporos Int. 2008 Apr;19(4):581-7.
     
  123. Langsetmo L, Hanley DA, Kreiger N, Prior J, Adachi JD, Davison KS, Kovacs C, Anastassiades T, Tenenhouse A, Goltzman D, and the CaMos Research Group.  Geographic variation of bone mineral density and selected risk factors for prediction of incident fracture among Canadians 50 and older. Bone 2008 Oct;43(4):672-678.
     
  124. Whitson HE, Sanders L, Pieper CF, Gold DT, Papaioannou A, Richards JB, Adachi JD, Lyles KW, and the CaMos Research Group.  Depressive symptomatology and fracture risk in community-dwelling older men and women. Aging Clin Exp Res. 2008 Dec;20(6):585-92.
     
  125. Waugh E, Lam M, Hawker GA, McGowan J, Papaioannou A, Cheung A, Hodsman AB, Leslie WD, Siminoski K.  Risk factors for low bone mass in healthy 40-60 year old women: a systematic review of the literature. Osteoporos Int. 2009 Jan;20(1):1-21.
     
  126. Langsetmo L, Goltzman D, Kovacs CS, Adachi JD, Hanley DA, Kreiger N, Josse R, Papaioannou A, Olszynski WP.  Repeat low-trauma fractures occur frequently among men and women who have osteopenic BMD.  J Bone Miner Res. 2009 Sep;24(9):1515-22.
     
  127. Papaioannou A, Kennedy CC, Ioannidis G, Sawka A, Hopman W, Pickard L, Brown JP, Josse RG, Kaiser S, Anastassiades T, Goltzman D, Papadimitropoulos M., Tenenhouse A, Prior JC, Olszynski WP, Adachi JD, for the CaMos Research Group.  The impact of incident fractures on health-related quality of life:  5 years of data from the Canadian Multicentre Osteoporosis Study.  Osteoporos Int. 2009 May;20(5):703-14.
     
  128. Giangregorio L, Dolovich L, Cranney A, Adili A, Debeer J, Papaioannou A, Thabane L, Adachi JD.  Osteoporosis risk perceptions among patients who have sustained a fragility fracture. Patient Educ Couns. 2009 Feb;74(2):213-20.
     
  129. Wong AKO, Inglis D, Beattie KA, Doan A, Ioannidis G, Adachi JD, Papaioannou A.  Reproducibility of computer-assisted joint alignment measurement in OA knee radiographs. Osteoarthritis Cartilage. 2009 May;17(5):579-85.
     
  130. Brown JP, Albert C, Nassar BA, Adachi JD, Cole D, Davison KS, Dooley KC, Don-Wauchope A, Douville P, Hanley DA, Josse R, Kaiser S, Krahn J, Krause R, Kremer R, Lepage R, Letendre E, Morin S, Ooi DS, Papaioaonnou A, Ste-Marie LG.  Bone turnover markers in the management of postmenopausal osteoporosis. Clin Biochem. 2009;42:929-942.
     
  131. Wong AKO, Beattie KA, Emond PD, Inglis D, Duryea J, Doan A, Ioannidis G, Webber CE, O’Neill J, de Beer J, Adachi JD, Papaioannou A. Quantitative analysis of subchondral sclerosis of the tibia by bone texture parameters in knee radiographs: site-specific relationships with joint space width. Osteoarthritis Cartilage. 2009 Nov;17(11):1453-60.
     
  132. Giangregorio LM, Jantzi M, Papaioannou A, Hirdes J, Maxwell CJ, Poss JW. Osteoporosis management among residents living in long-term care. Osteoporos Int. 2009 Sep;20(9):1471-8.
     
  133. Papaioannou A, Kennedy CC, Cranney A, Hawker G, Brown JP, Kaiser SM, Leslie WD, O’Brien CJM., Sawka AM, Khan A., Siminoski K, Tarulli G., Webster D., McGowan J, Adachi  JD.  Risk factors for low BMD in healthy men age 50 years or older: a systematic review.  Osteoporos Int 2009 Apr;20(4):507-18.
     
  134. Haaland D, Cohen D, Kennedy C, Khalidi N, Adachi J, Papaioannou A.  Closing the osteoporosis care gap: increased osteoporosis awareness among geriatrics and rehabilitation teams. BMC Geriatr. 2009 Jul 14;9:28.
     
  135. Ioannidis G, Papaioannou A, Thabane L, Gafni A, Hodsman A, Kvern B, Walsh A, Jiwa F, Adachi JD.  Family physicians’ personal and practice characteristics that are associated with improved utilization of bone mineral density testing and osteoporosis medication prescribing.  Popul Health Manag. 2009 Jun;12(3):131-8.
     
  136. Ioannidis G, Papaioannou A, Thabane L, Gafni A, Hodsman A, Kvern B, Walsh A, Jiwa F, Adachi JD.  The utilization of appropriate osteoporosis medications improves following a multifaceted educational intervention: the Canadian quality circle project (CQC).  BMC Med Educ. 2009 Aug;6;9:54.
     
  137. Mulgund M, Beattie KA, Wong AKO, Papaioannou A, Adachi JD.  Assessing adherence to teriparatide therapy, causes of nonadherence and effect of adherence on bone mineral density measurements in osteoporotic patients at high risk for fracture.  Therapeutic Advances in Musculoskeletal Disease.  Ther Adv Musculoskel Dis. 2009;1:5-12.
     
  138. Ioannidis G, Papaioannou A, Hopman WM, Akhtar-Danesh N, Anastassiades T, Pickard L, Kennedy CC, Prior JC, Olszynski WP, Davison KS, Goltzman D, Thabane L, Gafni A, Papadimitropoulos EA, Brown JP, Josse RG, Hanley DA, Adachi JD.  Relation between fractures and mortality: results from the Canadian Multicentre Osteoporosis Study.  CMAJ. 2009 Sep;181(5):265-71.
     
  139. Abid S, Papaioannou A.  Vertebral Compressions Fractures Among Older Adults. Geriatrics and Aging. 2009;12:10-20.
     
  140. Adachi JD, Kennedy CC, Papaioannou A, Ioannidis G, Leslie WD, Walker V. Treating osteoporosis in Canada: what clinical efficacy data should be considered by policy decision makers? Osteoporos Int. 2009 Oct;20(10):1785-93.
     
  141. Leslie WD, O’Donnell S, Jean S, Lagace C, Walsh P, Bancej C, Morin S, Hanley DA, Papaioannou A; Osteoporosis Surveillance Expert Working Group. Trends in hip fracture rates in Canada.  JAMA. 2009 Aug 26;302(8):883-89.
     
  142. Langsetmo LA, Morin S, Richards JB, Davison KS, Olszynski WP, Prior JC, Josse R, Goltzman D, and the CaMos Research Group.  Effectiveness of antiresorptives for the prevention of nonvertebral low-trauma fractures in a population-based cohort of women. Osteoporos Int. 2009 Feb;20(2):283-290.
     
  143. Chen P, Krege JH, Adachi JD, Prior JC, Tenenhouse A, Brown JP, Papadimitropoulos E, Kreiger N, Olszynski WP, Josse RG, Goltzman D, and the CaMos Research Group.  Vertebral fracture status and the world health organization risk factors for predicting osteoporotic fracture risk. J Bone Miner Res. 2009 Mar;24(3):495-502.
     
  144. Berger C, Langsetmo L, Joseph L, Hanley DA, Davison KS, Josse RG, Prior JC, Kreiger N, Tenenhouse A, Goltzman D, and the CaMos Research Group. Association between change in BMD and fragility fracture in women and men. J Bone Miner Res. 2009;24:361-370.
     
  145. Giangregorio LM, Thabane L, deBeer J, Farrauto L, McCartney N, Adachi JD, Papaioannou A.  Body weight-supported treadmill training for patients with hip fracture: a feasibility study. Arch Phys Med Rehabil. 2009 Dec;90:2125-30.
     
  146. Hopman WM, Berger C, Joseph L, Towheed T, Prior JC, Anastassiades T, Poliquin S, Zhou W, Adachi JD, Hanley DA, Papadimitropoulos EA, Tenenhouse A and the CaMos Research Group.  Health-Related Quality of Life in Canadian Adolescents and Young Adults: Normative Data using the SF-36. Can J Public Health. 2009 Nov-Dec;100(6):449-452.
     
  147. Langsetmo L, Poliquin S, Hanley D, Prior J, Barr S, Anastassiades T, Towheed T, Goltzman D, Kreiger N, and the CaMos Research Group.  Dietary patterns in Canadian men and women ages 25 and older: relationship to demographics, body mass index, and bone mineral density. BMC Musculoskelet Disord. 2010 Jan 28;11(1):20.
     
  148. Giangregorio L, Thabane L, Cranney A, Adili A, deBeer J, Dolovich L, Adachi JD, Papaioannou A. Osteoporosis knowledge among individuals with a recent fragility fracture. Orthop Nurs.  2010 Mar-Apr;29(2):99-107.
     
  149. Sawka AM, Ismaila N, Cranney A, Thabane L, Kastner M, Gafni A, Woodhouse LJ, Crilly R, Cheung AM, Adachi JD, Josse RG, Papaioannou A.  A scoping review of strategies for the prevention of hip fracture in elderly nursing home residents. PLoS ONE.  2010 Mar 3;5(3):e9515. Review.
     
  150. Jaglal SB, Hawker G, Cameron C, Canavan J, Beaton D, Bogoch E, Jain R, Papaioannou A; members of the Osteoporosis Research, Monitoring and Evaluation Working Group.  The Ontario Osteoporosis Strategy: implementation of a population-based osteoporosis action plan in Canada. Osteoporos Int. 2010 Jun;21(6):903-8.
     
  151. Grima DT, Papaioannou A, Airia P, Ioannidis G, Adachi JD.RAdverse events, bone mineral density and discontinuation associated with generic alendronate among postmenopausal women previously tolerant of brand alendronate: a retrospective cohort study. BMC Musculoskelet Disords. 2010 Apr 14;11:68.
     
  152. Papaioannou A, Kennedy CC, Campbell G, Stroud J, Wang L, Dolovich L, Crowther MA and the Improving Prescribing in Long Term Care Investigators. A team-based approach to warfarin management in long term care: A feasibility study of the MEDeINR electronic decision support system. BMC Geriatr. 2010 Jun 10;10:38.
     
  153. Coker E, Papaioannou A, Kaasalainen S, Dolovich L, Turpie I, Taniguchi A.  Nurses’ perceived barriers to optimal pain management in older adults on acute medical units.  Appl Nurs Res. 2010 Aug;23(3):139-46.
     
  154. Papaioannou A, Morin S, Cheung AM, Atkinson S, Brown JP, Feldman S, Hanley DA, Hodsman A, Kaiser SM, Kvern B, Siminoski K, Leslie WD for the Scientific Advisory Council of Osteoposis Canada.  2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary.  CMAJ. 2010 Nov 23;182(17):1864-73.
     
  155. Lau AN, Ioannidis G, Potts Y, Giangregorio LM, Van der Horst ML, Adachi JD, Papaioannou A.  What are the beliefs, attitudes and practices of front-line staff in long-term care (LTC) facilities related to osteoporosis awareness, management and fracture prevention?  BMC Geriatrics. 2010;10:73.
     
  156. Kaasalainen S, Brazil K, Coker E, Ploeg J, Martin-Misener R, Donald F, Dicenso A, Hadjistavropoulos T, Dolovich L, Papaioannou A, Emili A, Burns T.  An action-based approach to improving pain management in long-term care.  Can J Aging. 2010 Dec;29(4):503-17.
     
  157. Langsetmo L, Morin S, Kovacs CS, Kreiger N, Josse R, Adachi JD, Papaioannou A, Goltzman D, Hanley DA, Olszynski WP, Prior J; CaMos Research Group.  Determining whether women with osteopenic bone mineral density have low, moderate, or high clinical fracture risk.  Menopause. 2010 Sep-Oct;17(5):1010-16.
     
  158. Zhou W, Langsetmo L, Berger C, Adachi JD, Papaioannou A, Ioannidis G, Webber C, Atkinson SA, Olszynski WP, Brown JP, Hanley DA, Josse R, Kreiger N, Prior J, Kaiser S, Kirkland S, Goltzman D, Davison KS; CaMos Research Group.  Normative bone mineral density z-scores for Canadians aged 16 to 24 years: the Canadian Multicentre Osteoporosis Study.  J Clin Densitom. 2010;Jul-Sep;13(3):267-76.
     
  159. Jager PL, Slart RH, Webber CL, Adachi JD, Papaioannou A, Gulenchyn KY.  Combined vertebral fracture assessment and bone mineral density measurement: a patient-friendly new tool with an important impact on the Canadian Risk Fracture Classification.  Can Assoc Radiol J. 2010 Oct;61(4):194-200.
     
  160. Kaasalainen S, Agarwal G, Dolovich L, Papaioannou A, Brazil K, Akhtar-Danesh N. Nurses’ perceptions of and satisfaction with the medication administration system in long-term-care homes. Can J Nurs Res. 2010 Dec;42(4):58-79.
     
  161. Sawka AM, Ismaila N, Raina P, Straus S, Adachi JD, Gafni A, Papaioannou A.  Hip fracture prevention strategies in long-term care: A survey of Canadian physicians’ opinions. Can Fam Phys. 2010 Nov;56(11):e392-7.
     
  162. Berger C, Goltzman D, Langsetmo L, Joseph L, Jackson S, Kreiger N, Tenenhouse A, Davison KS, Josse RG, Prior JC, Hanley DA, and the CaMos Research Group. Peak bone mass from longitudinal data:implications for the prevalence, pathophysiology and diagnosis of osteoporosis. J Bone Miner Res. 2010;25:1948-1957.
     
  163. Langsetmo L, Leslie WD, Zhou W, Goltzman D, Kovacs CS, Prior JC, Josse RG, Olsyzynski WP, Davison KS, Anastassiades T, Towhead T, Hanley DA, Kaiser S, Kreiger N for the CaMos Research Group.  Using the same bone density reference database for men and women provides a simpler estimation of fracture risk. J Bone Miner Res. 2010;25:2108-2114.
     
  164. Jönsson B, Ström O, Eisman JA, Papaioannou A, Siris ES, Tosteson A, Kanis JA.  Cost-effectiveness of denosumab for the treatment of postmenopausal osteoporosis.  Osteoporos Int. 2011 Mar;22(3):967-82.
     
  165. Langsetmo L, Hanley DA, Prior JC, Barr SI, Anastassiades T, Towheed T, Goltzman D, Morin S, Poliquin S, Kreiger N, and the CaMos Research Group.  Dietary patterns and incident low-trauma fractures in postmenopausal women and men ages 50 and older: a population-based cohort study. Am J Clin Nutr. 2011;93:192-199.
     
  166. Szabo KA, Webber CE, Adachi JD, Tozer R, Gordon C, Papaioannou A.  Cortical and trabecular bone at the radius and tibia in postmenopausal breast cancer patients: A Peripheral Quantitative Computed Tomography (pQCT) study. Bone. 2011;48(2):218-24.
     
  167. Fraser LA, Ioannidis G, Adachi JD, Pickard L, Kaiser SM, Prior J, Brown JP, Hanley DA, Olszynski WP, Anastassiades T, Josse R, Goltzman D, Papaioannou A; the CaMos Research Group.  Fragility fractures and the osteoporosis care gap in women: the Canadian Multicentre Osteoporosis Study.  Osteoporos Int. 2011 Mar;22(3):789-96.
     
  168. Fraser LA, Langsetmo L, Berger C, Ioannidis G, Goltzman D, Adachi JD, Papaioannou A, Josse R, Kovacs CS, Olszynski WP, Towheed T, Hanley DA, Kaiser SM, Prior J, Kreiger N, Brown JP, Johansson H, Oden A, McCloskey E, Kanis JA, Leslie WD; CaMos Research Group.  Fracture prediction and calibration of a Canadian FRAX® tool: a population-based report from CaMos.  Osteoporos Int. 2011 Mar;22(3):829–37.
     
  169. Kaffashian S, Raina P, Oremus M, Pickard L, Adachi J, Papadimitropoulos E, Papaioannou A; CaMos Research Group.  The burden of osteoporotic fractures beyond acute care: the Canadian Multicentre Osteoporosis Study (CaMos). Age Ageing. 2011 Sep;40(5):602-607.
     
  170. Szabo KA, Webber CE, Gordon C, Adachi JD, Tozer R, Papaioannou A.  Reproducibility of peripheral quantitative computed tomography measurements at the radius and tibia in healthy pre- and postmenopausal women. Can Assoc Radiol J. 2011 Aug;62(3):183-9.
     
  171. Lentle B, Cheung AM, Hanley DA, Leslie WD, Lyons D, Papaioannou A, Atkinson S, Brown JP, Feldman S, Hodsman AB, Josse RG, Kaiser SM, Kvern B, Morin S, Siminoski K; Scientific Advisory Council of Osteoporosis Canada.  Osteoporosis Canada 2010 guidelines for the assessment of fracture risk.  Can Assoc Radiol J. 2011 Nov;62(4):243-50.
     
  172. Hopkins R, Goeree R, Pullenayegum E, Adachi JD, Papaioannou A, Xie F, Thabane L. The relative efficacy of nine osteoporosis medications for reducing the rate of fractures in post-menopausal women. BMC Musculoskelet Disord. 2011 Sep 26;12:209. Review.
     
  173. Kennedy CC, Campbell G, Garg AX, Dolovich L,  Stroud JB, McCallum RE, Papaioannou A.  Piloting a renal drug alert system for prescribing to residents in long-term care. J Am Geriatr Soc. 2011 Sep;59(9)1757-9.
     
  174. Papaioannou A, Kennedy CC, Giangregorio L, Ioannidis G, Pritchard J, Hanley DA, Farrauto L, DeBeer J, Adachi JD.  A randomized controlled trial of vitamin D dosing strategies after acute hip fracture: no advantage of loading doses over daily supplementation.  BMC Musculoskelet Disord. 2011 Jun 20;12:135.
     
  175. Fraser LA, Pritchard J, Ioannidis G, Giangregorio LM, Adachi JD, Papaioannou A, Leslie WD.  Clinical risk factors in diabetes: a matched cohort analysis.  J Clin Densitom. 2011 Oct-Dec;14(4):416-21.
     
  176. Jaglal SB, Donescu OS, Bansod V, Laprade J, Thorpe K, Hawker G, Majumdar SR, Meadows L, Cadarette SM, Papaioannou A, Kloseck M, Beaton D, Bogoch E, Zwarenstein M.  Impact of centralized osteoporosis coordinator on post-fracture osteoporosis management: a cluster randomized trial.  Osteoporos Int. 2012 Jan;23(1):87-95.
     
  177. Pritchard JM, Giangregorio LM, Atkinson SA, Beattie KA, Inglis D, Ioannidis G, Punthakee Z, Adachi JD, Papaioannou A.  Association of larger holes in the trabecular bone at the distal radius in postmenopausal women with type 2 diabetes mellitus compared to controls.  Arthritis Care Res. (Hoboken). 2012 Jan;64(1):83-91.
     
  178. Pritchard JM, Giangregorio LM, Ioannidis G, Papaioannou A, Adachi JD, Leslie WD.  Ankle fractures do not predict osteoporotic fractures in women with or without diabetes.  Osteoporos Int. 2012 Mar;23(3):957-62.
     
  179. Hopkins RB, Pullenayegum E, Pullenayegum E, Goeree R, Adachi JD, Papaioannou A, Leslie WD, Tarride JE, Thabane L.  Estimation of the lifetime risk of hip fracture for women and men in Canada.  Osteoporos Int. 2012 Mar;23(3):921-7.
     
  180. Cheung AM, Papaioannou A; Osteoporosis Canada Scientific Advisory Council Guidelines Committee.  Bone-density testing interval and transition to osteoporosis.  N Engl J Med. 2012 Apr 19;366(16):1546; author reply 1547-8.
     
  181. Kennedy CC, Ioannidis G, Giangregorio LM, Adachi JD, Thabane L, Morin SN, Crilly RG, Marr S, Josse RG, Lohfeld L, Pickard LE, King S, VanderHorst ML, Campbell G, Stroud J, Dolovich L, Sawka AM, Jain R, Nash L, Papaioannou A.  An interdisciplinary knowledge translation intervention in long-term care: Study protocol for the vitamin D and osteoporosis study (ViDOS) pilot cluster randomized controlled trial.  Implement Sci. 2012 May 24;7:48.
     
  182. Al-Shamsi HO, Lau AN, Malik K, Alamri A, Ioannidis G, Corbett T, Adachi JD, Papaioannou A.  The current practice of screening, prevention, and treatment of androgen-deprivation-therapy induced osteoporosis in patients with prostate cancer.  J Oncol. 2012;2012:958596.
     
  183. Ioannidis G, Kennedy CC, Dykeman J, Dudziak S, Papaioannou A.  Association between vitamin D3 supplementation and serum 25-hydroxyvitamin D levels in older individuals residing in long-term care in Ontario, Canada.  J Am Geriatr Soc. 2012 May;60(5):985-7.
     
  184. Jonsson B, Strom O,  Eisman JA, Papaioannou A, Siris ES, Tosteson A, Kanis JA.  Comment on: cost-effectiveness of denosumab for the treatment of postmenopausal osteoporosis.  Osteoporos Int. 2012 Jul;23(7):2063-5.
     
  185. Tarride JE, Guo N, Hopkins R, Leslie WD, Morin S, Adachi JD, Papaioannou A,  Bessette L, Brown JP, Goeree R.  The burden of illness of osteoporosis in Canadian men.  J Bone Miner Res. 2012 Aug;27(8):1830-8.
     
  186. Kaasalainen S, Brazil K, Akhtar-Danesh N, Coker E, Ploeg J, Donald F, Martin-Misener R, DiCenso A, Hadjistavropoulos T, Dolovich L, Papaioannou A.  The evaluation of an interdisciplinary pain control in long term care.  J Am Med Dir Assoc. 2012 Sep;13(7):664.
     
  187. Tarride JE, Hopkins RB, Leslie WD, Morin S, Adachi JD, Papaioannou A, Bessette L, Brown JP, Goeree R.  The burden of illness of osteoporosis in Canada.  Osteoporos Int. 2012 Nov;23(11):2591-600.
     
  188. Ioannidis G, Flahive J, Pickard L, Papaioannou A, Chapurlat RD, Saag KG, Silverman S, Anderson FA Jr, Gehlbach SH, Hooven FH, Boonen S, Compston JE, Cooper C, Díez-Perez A, Greenspan SL, Lacroix AZ, Lindsay R, Netelenbos JC, Pfeilschifter J, Rossini M, Roux C, Sambrook PN, Siris ES, Watts NB, Adachi JD; GLOW Investigators.  Non-hip, non-spine fractures drive healthcare utilization following a fracture: the Global Longitudinal Study of Osteoporosis in Women (GLOW).  Osteoporos Int. 2013 Jan;24(1):59-67.
     
  189. Giangregorio LM, MacIntyre NJ, Thabane L, Skidmore CJ, Papaioannou A.  Exercise for improving outcomes after osteoporotic vertebral fracture. Cochrane Database Syst Rev 2013 Jan 31;1:CD008618.
     
  190. Hopkins RB, Tarride JE, Leslie WD, Metge C, Lix LM, Morin S, Finlayson G, Azimaee M, Pullenayegum E, Goeree R, Adachi JD, Papaioannou A, Thabane L.  Estimating the excess costs for patients with incident fractures, prevalent fractures, and nonfracture osteoporosis.  Osteoporos Int. 2013 Feb;24(2):581-93.
     
  191. Pritchard JM, Giangregorio LM, Atkinson SA, Beattie KA, Inglis D, Ioannidis G, Gerstein H, Punthakee Z, Adachi JD,  Papaioannou A.  Changes in trabecular bone microarchitecture in postmenopausal women with and without type 2 diabetes: A two year longitudinal study. BMC Musculosket Disord. 2013 Mar 27;14:114.
     
  192. Fraser L-A, Leslie WD, Targownik LE, Papaioannou A, Adachi JD and CaMos  Research Group.  The effect of proton pump inhibitors on fracture risk: report from the Canadian Multicenter Osteoporosis Study.  Osteoporos Int. 2013 Apr;24(4):1161-1168.
     
  193. Pritchard JM, Papaioannou A, Tomowich C, Giangregorio LM, Atkinson SA, Beattie KA, Adachi JD, DeBeer J, Winemaker M, Avram V, Schwarcz HP. Bone mineralization is elevated and less heterogeneous in adults with type 2 diabetes and osteoarthritis compared to controls with osteoarthritis alone.  Bone 2013 May;54(1):76-82. 
     
  194. Jean S, O’Donnell S, Lacace C, Walsh P, Bancej C, Brown JP, Morin S, Papaioannou A, Jaglal SB, Leslie WD; Osteoporosis Surveillance Expert Working Group.  Trends in hip fracture rates in Canada: An age-period-cohort analysis.  J Bone Miner Res. 2013 Jun;28(6):1283-9.
     
  195. Langsmeto L, Berger C, Kreiger N, Kovacs CS, Hanley DA, Whiting SJ, Genest J, Morin SN, Hodsman A, Prior JC, Lentle B, Patel MS, Brown JP, Anastasiades T, Towheed T, Josse RG, Papaioannou A, Adachi JD, Leslie WD, Davison KS, Goltzman D; the CaMos Group.  Calcium and Vitamin D intake and mortality: Results from the Canadian Multicentre Osteoporosis Study (CaMos).  J Clin Endocrinol Metab. 2013 Jul;98(7):3010-8
     
  196. Li G, Mbuagbaw L, Samaan Z, Zhang S, Adachi JD, Papaioannou A, Thabane L.  Efficacy of vitamin D supplementation in depression in adults: a systematic review protocol.  Syst Rev. 2013 Aug 8;2:64.
     
  197. Wall M, Lohfeld L, Giangregorio L, Ioannidis G, Kennedy CC, Moser A, Papaioannou A, Morin SN.  Fracture risk assessment in long-term care: a survey of long-term care physicians.  BMC Geriatr. 2013 Oct 18;13(1):109.
     
  198. Johnson JA, McIlroy WE, Roy E, Papaioannou A, Thabane L, Giangregorio L.  Feasibility study of walking for exercise in individuals living in assisted settings.  J Geriatr Phys Ther. 2013 Oct-Dec;36(4):175-81.
     
  199. Kanis JA, Adachi JD, Cooper C, Clark P, Cummings SR, Diaz-Curiel M, Harvey N, Hilligsmann M, Papaioannou A, Pierroz DD, Silverman SL, Szulc P; The Epidemiology and Quality of Life Working Group of IOF.  Standardising the descriptive epidemiology of osteoporosis: recommendations from the Epidemiology and Quality of Life Working Group of IOF.  Osteoporos Int. 2013 Nov;24(11):2763-4.
     
  200. Fraser LA, Papaioannou A, Adachi JD, Ma J, Thabane L.  Risk factors for fracture in Diabetes: The Canadian Multicentre Osteoporosis Study”, ISRN Epidemiology, vol. 2013, Article ID 249874, 2013. Doi:10.5402/2013/249874.
     
  201. Dore N, Kennedy C, Fisher P, Dolovich L, Farrauto L, Papaioannou A.  Improving care after hip fracture: the fracture? Think Osteoporosis (FTOP) Program.  BMC Geriatr. 2013 Dec 5;13:130.
     
  202. O’Donnell S; Canadian Chronic Disease Surveillance System (CCDSS) Osteoporosis Working Group.  Use of administrative data for national surveillance of osteoporosis and related fractures in Canada: results from a feasibility study.  Arch Osteoporos 2013 Dec;8(1-2):143.
     
  203. St. Onge J, Ioannidis G, Papaioannou A, McLeod H, Marr S.  Impact of a mandatory geriatric medicine clerkship on the care of older medical patients: a retrospective cohort study.  BMC Med Educ., 2013 Dec 16;13(1):168.
     
  204. Rizzoli R, Body JJ, Brandi ML, Cannata-Andia J, Chappard D, El Maghraoui A, Gluer CC, Kendler D, Napoli N, Papaioannou A, Pierroz DD, Rahme M, Van Poznak CH, de Villiers TJ, El Hajj Fuleihan G; for the International Osteoporosis Foundation Committee on Scientific Advisors Working Group on Cancer-Induced Bone Disease.  Cancer-associated bone disease.  Osteoporos Int. 2013 Dec;24(12):2929-53.
     
  205. Lala D, Craven BC, Thabane L, Papaioannou A, Adachi JD, Popovic MR, Giangregorio LM.  Exploring the determinants of fracture risk among individuals with spinal cord injury.  Osteoporos Int. 2014 Jan;25(1):177-85.
     
  206. Li G, Mbuagbaw L, Samaan Z, Falavigna M, Zhang S, Adachi JD, Cheng J, Papaioannou A, Thabane L.  Efficacy of vitamin D supplementation in depression in adults: a systematic review. J Clin Endocrinol Metab. 2014 Mar;99(3):757-67.
     
  207. Giangregorio LM, Papaioannou A, Macintyre NJ, Ashe MC, Heinonen A, Shipp K, Wark J, McGill S, Keller H, Jian R, Kaprade J, Cheung AM.  Too Fit to Fracture: exercise recommendations for individuals with osteoporosis or osteoporotic vertebral fracture.  Osteoporos Int. 2014 Mar;25(3):821-35.
     
  208. Brown JP, Morin S, Leslie W, Papaioannou A, Cheung AM, Davison KS, Goltzman D, Hanley DA, Hodsman A, Josse R, Jovaisas A, Juby A, Kaiser S, Karaplis A, Kendler D, Khan A, Ngui D, Olszynski W, Ste-Marie LG, Adachi J.  Bisphosphonates for treatment of osteoporosis: expected benefits, potential harms, and drug holidays. Can Fam Physician. 2014 Apr;60(4):324-33.
     
  209. Fraser LA, Adachi JD, Leslie WD, Goltzman D, Josse R, Prior J, Kaiser S, Kreiger N, Kovacs CS, Anastassiades TP, Papaioannou A; for the CaMos Research Group.  Effect of Anticholinergic Medications on Falls, Fracture Risk, and Bone Mineral Density Over a 10-Year Period.  Ann Pharmacother. 2014 May 9;48(8):954-61.
     
  210. Moura C, Bernatsky S, Abrahamowicz M, Papaioannou A, Bessette L, Adachi J, Goltzman D, Prior J, Kreiger N, Towheed T, Leslie WD, Kaiser S, Ioannidis G, Pickard L, Fraser LA, Rahme E.  Antidepressant use and 10-year incident fracture risk: the population-based Canadian Multicentre Osteoporosis Study (CaMoS).  Osteoporos Int.  2014 May;25(5):1473-81.
     
  211. Giangregorio LM, MacIntyre NJ, Heinonen A, Cheung AM, Wark JD, Shipp K, McGill S, Ashe MC, Laprade J, Jain R, Keller H, Papaioannou A.  Too Fit To Fracture: a consensus on future research priorities in osteoporosis and exercise.  Osteoporos Int. 2014 May;25(5):1465-72.
     
  212. Li G, Ioannidis G, Pickard L, Kennedy C, Papaioannou A, Thabane L, Adachi JD.  Frailty index of deficit accumulation and falls: data from the Global Longitudinal Study of Osteoporosis in Women (GLOW) Hamilton cohort.  BMC Musculoskelet Disord. 2014 May 29;15(1):185.
     
  213. Fraser LA, Papaioannou A, Adachi JD, Ma J, Thabane L.  Fractures are increased and bisphosphonate use decreased in individuals with insulin-dependent diabetes: a 10 year cohort study.  BMC Musculoskelet Disord. 2014 Jun 11;15(1):201.
     
  214. Guthrie DM, Pitman R, Fletcher PC, Hirdes JP, Stolee P, Poss JW, Papaioannou A, Berg K, Ezekiel HJ. Data sharing between home care professionals: a feasibility study using the RAI Home Care instrument. BMC Geriatr. 2014 Jun 30;14:81.
     
  215. Khatib R, Yusuf S, Barzilay JI, Papaioannou A, Thabane L, Gao P, Joseph PG, Teo K, Mente A.  Impact of lifestyle factors on fracture risk in older patients with cardiovascular disease: a prospective cohort study of 26,335 individuals from 40 countries.  Age Ageing. 2014 Sep;43(5):629-35.
     
  216. Ioannidis G, Pallan S, Papaioannou A, Mulgund M, Rios L, Ma J, Thabane L, Davison KS, Josse RG, Kovacs CS, Kreiger N, Olszynski WP, Prior JC, Towheed T, Adachi JD; CaMos Research Group.  Glucocorticoids predict 10-year fragility fracture risk in a population-based ambulatory cohort of men and women: Canadian Multicentre Osteoporosis Study (CaMos).  Arch Osteoporos. 2014;9:169.
     
  217. Giangregorio LM, Thabane L, Adachi JD, Ashe MC, Bleakney RR, Braun EA, Cheung AM, Fraser LA, Gibbs JC, Hill KD, Hodsman AB, Kendler DL, Mittmann N, Prasad S, Scherer SC, Wark JD, Papaioannou A.  Build better bones with exercise: protocol for a feasibility study of a multicenter randomized controlled trial of 12 months of home exercise in women with a vertebral fracture.  Phys Ther. 2014 Sep;94(9):1337-52.
     
  218. Wong A K, Beattie, K A, Min K, Gordon C, Pickard L, Papaioannou A., & Adachi J D.  Peripheral quantitative computed tomography-derived muscle density and peripheral magnetic resonance imaging-derived muscle adiposity: precision and associations with fragility fractures in women.  J Musculoskelet Neuronal Interact, 2014 Dec;14(4), 401-410.
     
  219. Khatib R, Santesso N, Pickard L, Osman O, Giangregorio L, Skidmore C, Papaioannou A.  Fracture risk in long term care: a systematic review and meta-analysis of prospective observational studies.  BMC Geriatrics. 2014; Dec 3;14:130.
     
  220. Kennedy CC, Thabane L, Ioannidis G, Adachi JD, Papaioannou A; ViDOS Investigators.  Implementing a knowledge translation intervention in long-term care: feasibility results from the Vitamin D and Osteoporosis Study (ViDOS).  J Am Med Dir Assoc. 2014 Dec;15(12):943-5.
     
  221. McArthur C, Gibbs JC, Patel R, Papaioannou A, Neves P, Killingbeck J, Hirdes J, Milligan J, Berg K, Giangregorio L. (2017) A scoping review of physical rehabilitation in long-term care: interventions, outcomes, and tools. The Canadian Journal on Aging. 36 (4): 435-52.